相关实验视频
Updated: Apr 25, 2026

10:34
Ligand Nano-cluster Arrays in a Supported Lipid Bilayer
Published on: April 23, 2017
6.3K
可编程的纳米支架控制着对膜中的G蛋白结合受体的连接体显示,以允许剖析多价值效应
Andrew V Dix1, Steven M Moss, Khai Phan
1Laboratory of Bioorganic Chemistry, NIDDK, ‡Laboratory of Biochemistry and Genetics, NIDDK, and §Laboratory of Cell Biology, CCR, NCI, National Institutes of Health , Bethesda, Maryland 20892, United States.
Journal of the American Chemical Society
|August 14, 2014
概括
研究人员开发了一种可编程系统,以优化连接体与膜受体的结合. 这种方法改善了神经退行性疾病的药物向性,通过精确控制A2A腺受体的配体价值和间距.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 计算生物学 计算生物学
背景情况:
- 膜受体,如A2A腺受体,是神经退行性疾病的关键药物标.
- 了解多价值联体结合对于开发有效治疗方法至关重要.
- G蛋白结合受体 (GPCRs) 代表了一类重要的药物点.
研究的目的:
- 开发和使用可编程连接体显示系统来剖析多价值结合效应.
- 为了优化连接体配置,以增强与A2A腺受体的结合.
- 为了研究受体二极体在连接体结合中的作用.
主要方法:
- 使用可编程的连接体显示系统,创建了A2A腺受体抗剂的35种多价值配置.
- 通过实验确定了与A2A受体的联结亲和性.
- 基于统计力学开发了一个理论模型来解释绑定数据和指导连接体设计.
主要成果:
- 该研究确定了最佳的配体价值和间距,以改善与A2A腺受体的结合.
- 理论模型表明受体二极体在结合过程中的参与.
- 在A2A受体结合的逐步改善是通过扩展的多价值联结体安排实现的.
结论:
- 可控制的多价值显示系统可以精确优化连接体-受体相互作用.
- 这一策略有效地增强了对抗剂与膜受体 (如A2A腺) 的结合.
- 这些发现为设计神经退行性疾病中GPCR标的优化配体提供了一个框架.
相关概念视频
Assembly of Signaling Complexes
4.7K
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
4.7K
G Protein-coupled Receptors
14.0K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
14.0K
G Protein-coupled Receptors
2.4K
2.4K
G-protein Coupled Receptors
90.7K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
90.7K
G-protein Coupled Receptors
5.7K
5.7K
Transducer Mechanism: G Protein–Coupled Receptors
8.7K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
8.7K

